| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMSI | Common Stock, No Par Value | Award | $0 | +11.5K | +46.88% | $0.00 | 36.1K | Feb 27, 2025 | Direct | F1 |
| transaction | MMSI | Common Stock, No Par Value | Tax liability | -$414K | -4.2K | -11.62% | $98.50 | 31.9K | Feb 27, 2025 | Direct | F2 |
| transaction | MMSI | Common Stock, No Par Value | Award | $0 | +7.06K | +22.09% | $0.00 | 39K | Feb 28, 2025 | Direct | F3 |
| transaction | MMSI | Common Stock, No Par Value | Options Exercise | $1.12M | +25K | +64.11% | $44.80 | 64K | Feb 28, 2025 | Direct | |
| transaction | MMSI | Common Stock, No Par Value | Sale | -$2.49M | -25K | -39.07% | $99.50 | 39K | Feb 28, 2025 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MMSI | Non-qualified stock options (right to buy) | Options Exercise | $0 | -25K | -100% | $0.00 | 0 | Feb 28, 2025 | Common Stock | 25K | $44.80 | Direct | F5 |
| holding | MMSI | Non-qualified stock options (right to buy) | 30K | Feb 27, 2025 | Common Stock | 30K | $55.73 | Direct | F6 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 16.7K | Feb 27, 2025 | Common Stock | 16.7K | $37.71 | Direct | F7 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 9.68K | Feb 27, 2025 | Common Stock | 9.68K | $56.25 | Direct | F8 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 8.09K | Feb 27, 2025 | Common Stock | 8.09K | $65.03 | Direct | F9 | |||||
| holding | MMSI | Non-qualified stock options (right to buy) | 13.6K | Feb 27, 2025 | Common Stock | 13.6K | $70.58 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022. |
| F2 | The Reporting Person surrendered 4,198 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market. |
| F3 | Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting. |
| F4 | The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.56 to $100.0525, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F5 | Become exercisable in equal annual installments of 20% commencing on 03/02/2019. |
| F6 | Become exercisable in equal annual installments of 20% commencing on 03/01/2020. |
| F7 | Become exercisable in equal annual installments of 25% commencing on 02/26/2021. |
| F8 | Become exercisable in equal annual installments of 25% commencing on 03/19/2022. |
| F9 | Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. |
| F10 | Become exercisable in equal annual installments of 25% commencing on 02/28/2024. |